Literature DB >> 22980732

Solving the lost in translation problem: improving the effectiveness of translational research.

Ceren Ergorul1, Leonard A Levin.   

Abstract

Translational research frequently fails to replicate in the clinic what has been demonstrated in the laboratory. This has been true for neuroprotection in the central nervous system, neuroprotection in glaucoma, as well as many other areas of medicine. Two fundamental reasons for this 'Lost in Translation' problem are the 'Butterfly Effect' (chaotic behavior of many animal models) and the 'Two Cultures' problem (differences between the methodologies for preclinical and clinical research). We propose several strategies to deal with these issues, including the use of ensembles of animal models, adding intraocular pressure lowering to preclinical neuroprotection studies, changing the way in which preclinical research is done, and increasing interactions between the preclinical and clinical teams.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22980732      PMCID: PMC3529749          DOI: 10.1016/j.coph.2012.08.005

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  63 in total

1.  A novel method for the induction of experimental glaucoma using magnetic microspheres.

Authors:  Paulina A Samsel; Lilian Kisiswa; Jonathan T Erichsen; Stephen D Cross; James E Morgan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-25       Impact factor: 4.799

Review 2.  Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma--a review.

Authors:  Subha T Venkataraman; John G Flanagan; Chris Hudson
Journal:  Microcirculation       Date:  2010-10       Impact factor: 2.628

Review 3.  Comparison of treatment effects between animal experiments and clinical trials: systematic review.

Authors:  Pablo Perel; Ian Roberts; Emily Sena; Philipa Wheble; Catherine Briscoe; Peter Sandercock; Malcolm Macleod; Luciano E Mignini; Pradeep Jayaram; Khalid S Khan
Journal:  BMJ       Date:  2006-12-15

4.  The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice.

Authors:  Rebecca M Sappington; Brian J Carlson; Samuel D Crish; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

5.  The case report. When small is beautiful.

Authors:  L A Levin; N Bressler
Journal:  Arch Ophthalmol       Date:  1996-11

6.  Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat.

Authors:  Michael Blair; Mary Ellen Pease; John Hammond; Danielle Valenta; Jennifer Kielczewski; Hana Levkovitch-Verbin; Harry Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-03       Impact factor: 4.799

7.  Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage.

Authors:  Iok-Hou Pang; Elaine C Johnson; Lijun Jia; William O Cepurna; Allan R Shepard; Mark R Hellberg; Abbot F Clark; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

Review 8.  Glaucoma: genes, phenotypes, and new directions for therapy.

Authors:  Bao Jian Fan; Janey L Wiggs
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 9.  TNF-alpha signaling in glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

10.  Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration.

Authors:  M Francesca Cordeiro; Li Guo; Vy Luong; Glen Harding; Wei Wang; Helen E Jones; Stephen E Moss; Adam M Sillito; Frederick W Fitzke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

View more
  15 in total

Review 1.  Nonhuman primate models in the genomic era: a paradigm shift.

Authors:  Eric J Vallender; Gregory M Miller
Journal:  ILAR J       Date:  2013

Review 2.  Pharmacotherapy of glaucoma.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-14       Impact factor: 2.671

3.  A pain research agenda for the 21st century.

Authors:  Robert W Gereau; Kathleen A Sluka; William Maixner; Seddon R Savage; Theodore J Price; Beth B Murinson; Mark D Sullivan; Roger B Fillingim
Journal:  J Pain       Date:  2014-10-29       Impact factor: 5.820

Review 4.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

5.  Surgical extraction of human dorsal root ganglia from organ donors and preparation of primary sensory neuron cultures.

Authors:  Manouela V Valtcheva; Bryan A Copits; Steve Davidson; Tayler D Sheahan; Melanie Y Pullen; Jordan G McCall; Krikor Dikranian; Robert W Gereau
Journal:  Nat Protoc       Date:  2016-09-08       Impact factor: 13.491

Review 6.  Neuroprotection for glaucoma: Requirements for clinical translation.

Authors:  Leonard A Levin; Megan E Crowe; Harry A Quigley
Journal:  Exp Eye Res       Date:  2016-12-09       Impact factor: 3.467

Review 7.  Human reconstructed kidney models.

Authors:  Seiji Kishi; Takuya Matsumoto; Takaharu Ichimura; Craig R Brooks
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-16       Impact factor: 2.416

8.  The innovative medicines initiative: a public private partnership model to foster drug discovery.

Authors:  Elisabetta Vaudano
Journal:  Comput Struct Biotechnol J       Date:  2013-11-27       Impact factor: 7.271

9.  Animal models are essential to biological research: issues and perspectives.

Authors:  Françoise Barré-Sinoussi; Xavier Montagutelli
Journal:  Future Sci OA       Date:  2015-11-01

10.  Impact of Stroke Therapy Academic Industry Roundtable (STAIR) Guidelines on Peri-Anesthesia Care for Rat Models of Stroke: A Meta-Analysis Comparing the Years 2005 and 2015.

Authors:  Aurelie Thomas; Johann Detilleux; Paul Flecknell; Charlotte Sandersen
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.